BFC Planning’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
BFC Planning's ARKG Position: Q3 2026 in Review
BFC Planning reduced its ARK Genomic Revolution ETF (ARKG) stake by 98% in Q3 2026, selling an estimated $15.6K and leaving 6 shares worth $325. The position accounts for ﹤0.01% of the portfolio, ranked #3326.
BFC Planning first reported a position in ARKG in Q3 2024 and has held it in 9 quarters since. The position peaked at $18.7K in Q4 2025. 260 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- BFC Planning held 6 shares of ARK Genomic Revolution ETF worth $325 as of Q3 2026.
- BFC Planning sold 347 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $15.6K.
- ARK Genomic Revolution ETF made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3326 holding.
- BFC Planning first reported a position in ARK Genomic Revolution ETF in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's ARK Genomic Revolution ETF position peaked at $18.7K in Q4 2025.
- 260 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.